Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KLINISK TANDTEKNIKER SØREN SØRENSEN ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.2% 2.2%   Bankruptcy risk   2.8% 3.0% 2.8% 3.0% 3.0% 2.9% 16.4% 16.4%   Credit score (0-100)   61 58 59 56 57 57 11 11   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,362 1,358 1,139 1,336 1,174 1,235 0.0 0.0   EBITDA   721 740 469 709 542 623 0.0 0.0   EBIT   719 737 465 706 516 552 0.0 0.0   Pre-tax profit (PTP)   718.6 734.2 462.6 700.9 511.9 552.5 0.0 0.0   Net earnings   559.4 568.1 359.8 546.4 405.2 424.1 0.0 0.0   Pre-tax profit without non-rec. items   719 734 463 701 512 552 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   13.5 10.4 7.3 4.1 314 243 0.0 0.0   Shareholders equity total   715 783 543 689 494 538 38.5 38.5   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   990 1,090 848 1,008 737 824 38.5 38.5   Net Debt   -495 -595 -302 -736 -163 -469 -38.5 -38.5     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,362 1,358 1,139 1,336 1,174 1,235 0.0 0.0   Gross profit growth   2.4% -0.3% -16.1% 17.3% -12.1% 5.1% -100.0% 0.0%   Employees   1 1 0 0 1 1 0 0   Employee growth %   0.0% 0.0% -100.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   990 1,090 848 1,008 737 824 38 38   Balance sheet change%   7.7% 10.1% -22.2% 18.9% -26.9% 11.8% -95.3% 0.0%   Added value   721.0 739.8 468.6 709.1 519.4 623.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   11 -6 -6 -6 284 -142 -243 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   52.8% 54.3% 40.9% 52.8% 44.0% 44.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   75.3% 70.8% 48.0% 76.1% 59.2% 70.8% 0.0% 0.0%   ROI %   104.9% 98.4% 70.2% 114.6% 86.6% 105.1% 0.0% 0.0%   ROE %   81.6% 75.8% 54.3% 88.7% 68.5% 82.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   72.2% 71.8% 64.0% 68.4% 67.1% 65.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -68.7% -80.4% -64.5% -103.8% -30.0% -75.2% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   3.5 3.5 2.7 3.1 1.8 2.1 0.0 0.0   Current Ratio   3.5 3.5 2.7 3.1 1.8 2.1 0.0 0.0   Cash and cash equivalent   495.1 594.8 302.2 736.2 162.6 468.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   696.6 765.1 529.8 680.4 190.3 304.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   721 740 0 0 519 623 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   721 740 0 0 542 623 0 0   EBIT / employee   719 737 0 0 516 552 0 0   Net earnings / employee   559 568 0 0 405 424 0 0